Total Funding
33
13
Total FundingSeries A raised
Growth Score
-4 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
222332
NuMedii is a biotechnology company that discovers and de-risks effective drugs by translating life sciences big data into therapies.
Atul Butte: Co-Founder & Scientific AdvisorPast Role: Carmenta Bioscience, Co-founder and Scientific Advisor
Linda Ara: Chief Financial Officer
About the Company
NuMedii is a biotechnology company that discovers and de-risks effective new drugs by translating life sciences big data into therapies. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii. It utilizes hundreds of millions of raw human, biological,
pharmacological, and clinical data points.
The company was founded in 2008 and headquartered in San Mateo, California.
Women Founded
Women Led
